Most Ditch GLP-1 Drugs for Weight Loss Within a Year
Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly higher for patients without versus with type 2 diabetes (64.8% vs 46.5%), reported Ezekiel J. Emanuel, MD, PhD, of the University of Pennsylvania in Philadelphia, and colleagues.
Hosted on MSN2d
Think Beyond GLP-1: True Weight Loss Requires MoreGLP-1 medications have become popular for weight loss, and for good reason—they can help regulate appetite and support weight ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
GLP-1 medications such as Ozempic and Wegovy have had a transformative effect for those struggling with weight loss. Many ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.
7don MSN
The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...
American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some ...
Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...
Axios Vitals on MSN4d
Demand for GLP-1s for weight loss is surging in North Carolina, just like it is nationwideThe number of prescriptions for anti-obesity GLP-1 drugs like Wegovy and Ozempic is rising in North Carolina, just as it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback